Join the 5th edition of this international brokerage event dedicated to Horizon Europe Cluster 1 Health and the EU Cancer Mission.
The event brings together researchers, healthcare professionals, innovators, companies, policymakers and other stakeholders interested in building strong international consortia for the upcoming 2027 Horizon Europe calls.
Participants will:
- Learn about the 2027 funding opportunities from representatives of the European Commission and leading European experts.
- Meet potential project partners from across Europe.
- Present their project ideas during pitching sessions.
- Take part in matchmaking meetings and networking activities.
- Exchange ideas and develop competitive Horizon Europe proposals.
The brokerage event is organised just before the EU Cancer Mission Showcase (29 September-1 October 2026, Brussels), giving participants the opportunity to attend both events during the same visit. Together, they offer an excellent opportunity to expand your network, discover new collaboration opportunities and prepare successful Horizon Europe proposals.
Pitching session themes
- Healthcare Innovation
- Clinical Trials
- Digital Health & Artificial Intelligence
Event details
📅 Date: September 28, 2026, 12:30- 19:00 (CEST)
📍Venue :Comet Meetings (Pl. Stéphanie 20, 1050 Bruxelles)
📃 A preliminary agenda is available at the bottom of this page.
📝 Registration will open in due course.
Horizon Europe calls covered by the event
Healthcare innovations:
- Leveraging functional genomics to reveal novel targets for cancer treatment HORIZON-MISS-2027-02-CANCER-01
- Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications HORIZON-HLTH-2027-01-CARE-02
- Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research HORIZON-MISS-2027-02-CANCER-04
- Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines HORIZON-MISS-2027-02-CANCER-05
Clinical trials:
- Prevention and management of chronic non-communicable diseases in children and young people (GACD) HORIZON-HLTH-2027-01-DISEASE-10
- Clinical trials for advancing innovative interventions for neurodegenerative diseases HORIZON-HLTH-2027-02-DISEASE-14-two-stage
- Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes HORIZON-MISS-2027-02-CANCER-03
- Innovative healthcare interventions for non-communicable diseases HORIZON-HLTH-2027-02-DISEASE-01-two-stage
Digital health and AI:
- Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis HORIZON-HLTH-2027-03-TOOL-04
- Towards Artificial General Intelligence (AGI) for healthcare HORIZON-HLTH-2027-03-TOOL-08
- Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases HORIZON-HLTH-2027-02-TOOL-01-two-stage
Co-organizers and partners
The event is co-organised by the Research Council of Lithuania National Contact Point and the National Centre for Research and Development National Contact Point (NCBR, Poland), in collaboration with the Lithuanian Research Development and Innovation Liaison Office in Brussels (LINO), the NCBR Office in Brussels and National Contact Points from Belgium, and in partnership with the National Contact Points from France, Estonia and Latvia.
